 







<USDEPT>DEPARTMENT OF HEALTH AND HUMAN SERVICES</USDEPT>



<USBUREAU>Food and Drug Administration</USBUREAU>


Termination of Temporary Deferment of Activities Relating to Biologics Submissions and Notice of New Mailing Address;
Correction


<AGENCY>
AGENCY:

 Food and Drug Administration, HHS.


</AGENCY>
<ACTION>
ACTION:

 Notice; correction.




</ACTION>
<SUMMARY>
SUMMARY:

 The Food and Drug Administration (FDA) is correcting a notice that appeared in the 

Federal Register

 of September 23, 1994 (59 FR 48895). The document announced the new address for submissions and identified the exact
period which action on pending submissions was temporarily deferred. The agency also announced the installation
of automated systems to make information available to the public and to help callers identify the new telephone numbers
of Center for Biologics and Evaluation staff involved in review activities. The document was published with a typographical
error. This document corrects that error.


</SUMMARY>
<FURTHER>
FOR FURTHER INFORMATION CONTACT:

 LaJuana D. Caldwell, Office of Policy (HF27), Food and Drug Administration, 5600 Fishers Lane, Rockville,
MD 20857, 3014432994.




In FR Doc. 9423617, appearing on page 48895, in the 

Federal Register

 of September 23, 1994, the following correction is made:
On page 48895, in the second column, in the fourth line from the bottom, the phone number ``5495656'' is corrected
to read ``5945656''.




Dated: November 17, 1994.

</FURTHER>
<SIGNER>
William K. Hubbard,

</SIGNER>
<SIGNJOB>
Interim Deputy Commissioner for Policy.

</SIGNJOB>
<FRFILING>
[FR Doc. 9429115 Filed 112594; 8:45 am]

</FRFILING>
<BILLING>
BILLING CODE 416001F
</BILLING>

